In Carda Therapeutics, Inc. announced it raised $28 Million in an initial filing from an offering of $50 Million

Oct 21, 2020•over 4 years ago

Amount Raised

$28 Million

NewarkHealthcare

Company Information

Company

InCarda Therapeutics, Inc.

Location

39899 BALENTINE DRIVE, SUITE 185

Newark, California, United States

About

InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

In Carda Therapeutics, Inc. announced it raised $28 Million in an initial filing from an offering of $50 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information